Authors' Reply: Reconsidering Biomarker Interpretation and Clinical Applicability in High-Intensity Interval Training and Kidney Function Trials

We thank Dr. Sharma1 for the interesting commentary on our article “Long-Term Physical Exercise for Preventing CKD in Older Adults: A Randomized Clinical Trial,” published in JASN.2 The letter suggests that the effect of exercise on cystatin C could be biased by the off-target effects of exercise on inflammation and thyroid function. Although exercise might have a modest effect on these parameters, their contribution to cystatin C levels is very small so the potential influence on our trial results seems only theoretical. By contrast, the effect of exercise on muscle turnover is very direct and leads to immediate changes in creatinine production. Dr. Sharma's comments regarding the generalizability and population impact of our clinical trial are all important considerations. We chose to evaluate the effects of physical exercise in a low-risk population, so of course we used eGFR-based outcomes as has been endorsed by both Kidney Disease Improving Global Outcomes and the US Food and Drug Administration. Intervention trials in nephrology have previously been very difficult to undertake because of the very long timeline in patients with CKD. We believe strongly that nephrology interventions should focus on the early stages of CKD, before irreversible structural damage with fibrosis replacement occurs. Caution should indeed be taken when generalizing and implementing such data into clinical practice, and individualizing to the specific patient will be important. Adherence to assigned interventions is always an issue in clinical research and practice. In a randomized trial like the Generation 100, this will attenuate the effect of the treatment with a bias toward the null result. Therefore, our results are extraordinary in demonstrating the benefits of randomization to an exercise intervention compared with an active control arm. We do agree that our observational analyses of the achieved activity could be biased by unmeasured confounding. Interpretation of the true intervention effect is therefore complicated, as pointed out by Dr. Sharma, but all analyses point in the same direction: Physical exercise preserves kidney function, and higher levels of activity are more effective. The optimal implementation of this new knowledge into real-world practice is not yet known, but we were at least able to include 20% of the general population in this study. Furthermore, high-intensity training is always on a relative scale, which enables participation even for people at older ages and with some degree of frailty and comorbidity.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-09-15
DOI
https://doi.org/10.1681/asn.0000000862
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Authors' Reply: Reconsidering Biomarker Interpretation and Clinical Applicability in High-Intensity Interval Training and Kidney Function Trials

Stein Hallan, Knut Asbjørn Rise Langlo, Michael G. Shlipak
Journal of the American Society of Nephrology
Dialysis and Renal Disease Management
article

Authors' Reply: Reconsidering Biomarker Interpretation and Clinical Applicability in High-Intensity Interval Training and Kidney Function Trials

Stein Hallan, Knut Asbjørn Rise Langlo, Michael G. Shlipak
article en

Abstract

We thank Dr. Sharma1 for the interesting commentary on our article “Long-Term Physical Exercise for Preventing CKD in Older Adults: A Randomized Clinical Trial,” published in JASN.2 The letter suggests that the effect of exercise on cystatin C could be biased by the off-target effects of exercise on inflammation and thyroid function. Although exercise might have a modest effect on these parameters, their contribution to cystatin C levels is very small so the potential influence on our trial results seems only theoretical. By contrast, the effect of exercise on muscle turnover is very direct and leads to immediate changes in creatinine production. Dr. Sharma's comments regarding the generalizability and population impact of our clinical trial are all important considerations. We chose to evaluate the effects of physical exercise in a low-risk population, so of course we used eGFR-based outcomes as has been endorsed by both Kidney Disease Improving Global Outcomes and the US Food and Drug Administration. Intervention trials in nephrology have previously been very difficult to undertake because of the very long timeline in patients with CKD. We believe strongly that nephrology interventions should focus on the early stages of CKD, before irreversible structural damage with fibrosis replacement occurs. Caution should indeed be taken when generalizing and implementing such data into clinical practice, and individualizing to the specific patient will be important. Adherence to assigned interventions is always an issue in clinical research and practice. In a randomized trial like the Generation 100, this will attenuate the effect of the treatment with a bias toward the null result. Therefore, our results are extraordinary in demonstrating the benefits of randomization to an exercise intervention compared with an active control arm. We do agree that our observational analyses of the achieved activity could be biased by unmeasured confounding. Interpretation of the true intervention effect is therefore complicated, as pointed out by Dr. Sharma, but all analyses point in the same direction: Physical exercise preserves kidney function, and higher levels of activity are more effective. The optimal implementation of this new knowledge into real-world practice is not yet known, but we were at least able to include 20% of the general population in this study. Furthermore, high-intensity training is always on a relative scale, which enables participation even for people at older ages and with some degree of frailty and comorbidity.

Journal of the American Society of NephrologyVol. 36(11)
San Francisco VA Medical Center (US), Norwegian University of Science and Technology (NO), St Olav's University Hospital (NO)
Openalex Percentile: Top 74%
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.